IBANDRONATE SODIUM is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Tagi Pharma, Inc.. The primary component is Ibandronate Sodium.
| Product ID | 51224-008_4d64c479-f90c-40a5-bfaf-c92f884b5133 |
| NDC | 51224-008 |
| Product Type | Human Prescription Drug |
| Proprietary Name | IBANDRONATE SODIUM |
| Generic Name | Ibandronate Sodium |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-06-30 |
| Marketing Category | ANDA / |
| Application Number | ANDA204329 |
| Labeler Name | TAGI Pharma, Inc. |
| Substance Name | IBANDRONATE SODIUM |
| Active Ingredient Strength | 3 mg/3mL |
| Pharm Classes | Bisphosphonate [EPC], Diphosphonates [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-06-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 23155-162 | Ibandronate sodium | Ibandronate sodium |
| 25021-827 | ibandronate sodium | ibandronate sodium |
| 33342-150 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 47781-103 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 51224-008 | IBANDRONATE SODIUM | Ibandronate Sodium |
| 55111-575 | Ibandronate sodium | Ibandronate sodium |
| 55150-191 | Ibandronate Sodium | Ibandronate Sodium |
| 60429-643 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 60505-2795 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 60505-6097 | Ibandronate Sodium | ibandronate sodium |
| 62756-218 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 65862-237 | Ibandronate Sodium | Ibandronate Sodium |
| 67457-524 | ibandronate sodium | ibandronate sodium |
| 0004-0186 | Boniva | ibandronate sodium |
| 0004-0191 | Boniva | ibandronate sodium |